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C hronic kidney disease (CKD) is known to increase the risk of cardiovascular (CV) events 
and the overall death rate [1-3].  Radical nephrectomy 
(RN) for renal cell carcinoma (RCC) has been shown to 
be associated with an increased risk of new-onset CKD 
compared to a partial nephrectomy (PN) [4].  Many 
researchers thus agree that PN is the preferred surgical 
option for RCCs,  even in patients with a normal con-
tralateral kidney [5-9].  The rationale for the wider use 
of PN is based on evidence that suggests a similar level 
of cancer control can be achieved with PN compared to 
RN,  while preserving renal function with a PN [5-7,  
10-12].  Although several studies investigated the 
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We retrospectively analyzed the factors related to postoperative cardiovascular (CV) events in patients under-
going partial nephrectomy (PN) or radical nephrectomy (RN) for clinical T1 renal cell carcinoma (RCC).  We 
identified 570 patients who underwent PN or RN for T1 renal cell carcinoma between January 1998 and 
December 2009 at our institution and related hospitals.  We determined the cumulative incidence rate of CV 
events and overall survival (OS) using Kaplan-Meier survival curves with a log-rank test,  and we evaluated the 
risk for an increase in CV events and OS using Cox proportional hazard regression.  Of the 570 patients,  171 
underwent PN and 399 underwent RN.  The type of surgery was not significantly related with CV events.  The 
only factor that significantly increased the risk of CV events in both the univariate (HR 2.67,  p= 0.006) and 
multivariate analyses (HR 2.14,  p= 0.044) was a postoperative estimated glomerular filtration rate (eGFR) 
< 45 ml/min/1.73 m2.  Postoperative eGFR was also a significant risk factor for OS in the univariate analysis 
(HR 2.38,  p= 0.0104),  but not in the multivariate model.  Postoperative renal function was a significant inde-
pendent predictor of the incidence of subsequent CV events.
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impact of PN and postoperative renal function on CV 
events and overall survival (OS) [10-15] the question of 
whether preserving a patient’s postoperative renal func-
tion lowers the risk of CV events remains unanswered.  
The objective of this study was to determine the factors 
related to postoperative CV events in patients undergo-
ing a partial or radical nephrectomy for localized RCC.
Patients and Methods
Patients who underwent either an RN or a PN for 
newly diagnosed localized RCC at our institution and 
related hospitals between January 1998 and December 
2009 were enrolled in this study.  A total of 700 consec-
utive patients fulfilled the following criteria: (1) The 
cohort was restricted to a localized RCC; (2) the pre-
operative radiological examination did not find lymph 
node metastasis or distant metastasis; (3) postoperative 
adjuvant chemotherapy had not been performed.  
Seventy-two patients with clinical T2 RCC were 
excluded from the study because all but one of the 
patients who underwent a PN had clinical T1a or T1b 
RCCs.  Fifty-eight patients were excluded from the 
analysis because they were on dialysis or had only one 
kidney.  A total of 570 patients were eligible for this ret-
rospective study.  The surgical approach (open or lapa-
roscopic approach) in each case was determined by 
considering the complexity of the renal mass and the 
preference of the surgeon.
The patients’ demographics,  clinical stage,  periop-
erative and pathological data were obtained from our 
kidney cancer patient registry.  CV-related diseases such 
as diabetes,  hypertension,  cardiovascular disease,  and 
cerebrovascular disease were defined as the respective 
diagnosis identified in medical records.  This study was 
approved by our institutional review board (IRB# 1607-
012).  The estimated glomerular filtration rate (eGFR) 
was calculated using the abbreviated Modification of 
Diet in Renal Disease (MDRD) study equation as:  
186 × sCr−1.154 × age−0.203 × (0.742 if female),  expressed as 
ml/min/1.73 m2 [16].  The postoperative eGFR was cal-
culated using the serum creatinine level measured 3 
months after surgery.
The primary endpoints of the analysis were the onset 
of at least one new CV event after renal surgery and the 
cumulative CV incidence rate.  The secondary endpoint 
of the analysis was OS.  The CV events were defined as 
one of following: myocardial or cerebral infarction,  
ischemic stroke,  transient ischemic attack,  percutane-
ous coronary intervention,  coronary artery bypass graft 
surgery,  and hospitalization for the diagnosis of acute 
angina,  congestive heart failure,  coronary artery dis-
ease,  peripheral vascular disease,  or cerebral stroke as 
identified in medical records.  The incidence of CV 
events and the OS were determined as the interval from 
the date of renal surgery to the occurrence of the event.
Unadjusted associations between the type of surgery 
(PN vs. RN) and patient characteristics were examined 
using chi-square statistics.  The relationship between the 
type of surgery and each primary endpoint was evalu-
ated in a time-to-event framework.  Kaplan-Meier sur-
vival curves were constructed for cumulative CV inci-
dence,  and the differences in survival were compared 
using a log-rank test.  We set eGFR <45 mL/min/1.73 m2 
as the cut-off value for postoperative renal dysfunction.  
Multivariate Cox proportional hazards regression was 
used to assess the effect on the hazards at each endpoint,  
controlled for demographic and clinical characteristics.
We also examined the interactions between the type 
of surgery and patient characteristics,  including pre- 
existing comorbidities.  All of the analyses were per-
formed using the JMP ver. 9 statistical package (SAS 
Institute,  Cary,  NC,  USA),  with p-values < 0.05 con-
sidered significant.
Results
Patient characteristics and predictors of treatment.
The study cohort included 570 patients who had under-
gone definitive surgery for clinical T1 RCC diagnosed 
between 1998 and 2009.  Of these patients,  171 had 
undergone a PN and 399 had undergone an RN (Table 
1).  The RN patients were significantly older (p = 0.0021) 
and had significantly larger tumors (p = 0.0270).  The 
median postoperative eGFR values were 50.6 vs. 
68.8ml/min/1.73 m2 for the RN and PN groups,  
respectively (p < 0.0001).  The median follow-up dura-
tion was 57 months.  PN preserved renal function better 
than RN,  as seen by the median rate of change in eGFR 
of −12.4% in the PN group and −35.2% in the RN 
group.
A subgroup analysis of the patients with a preopera-
tive eGFR ≥ 60 ml/min/1.73 m2 showed that the pro-
portions of patients with a postoperative eGFR ≥ 60 or 
45-60 were 76.4% and 18.8% in the PN group,  and 
33.4% and 40.2% in the RN group,  respectively.
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Cardiovascular events. A total of 34 patients had 
at least one CV event after surgery,  including 6 (3.5%) 
in the PN group and 28 (7.0%) in the RN group.  The 3- 
and 5-year probabilities of cumulative CV event inci-
dence were 1.2% and 3.1% in the PN group and 2.6% 
and 4.8% in the RN group,  respectively (Fig. 1A),  with 
no significant difference between the 2 groups.  When 
the patients were stratified into 2 groups with a postop-
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Table 1　 Demographic and clinical characteristics of the patients
Feature Total PN RN P-value
No. of patients 570 171 399
Median age at surgery (IQR)  65 (54-73)  61 (52-72)  66 (56-74) 0.0021
Median preop eGFR (IQR) 79.0 (63.5-92.7) 79.4 (64.1-93.7) 78.8 (62.8-91.2) 0.5120
Preop eGFR ≥60 (ml/min/1.73 m2) (%) 470 (82.5) 144 (84.2) 326 (81.7) 0.4709
Median postop eGFR (ml/min/1.73 m2) (IQR) 54.9 (43.6-70.5) 68.8 (54.8-83.7) 50.6 (41.6-62.1) ＜0.0001
Median clinical tumor size (cm) (IQR)  3.3 (2.3-4.5)  2.2 (1.7-3.0)  4.0 (3.0-5.0) 0.027
Clinical stage: ＜0.0001
　　cT1a 356 (62.5) 157 (91.8) 199 (49.9)
　　cT1b 214 (37.5)  14 (8.2) 200 (50.1)
No. (%): 0.0020
　　Female 178 (31.1)  38 (22.2) 140 (35.1)
　　Male 392 (68.8) 133 (77.8) 259 (64.9)
No. laparoscopic (%): 189 (33.2)  38 (22.2) 151 (37.8) 0.0003
No. malignant histological subtype (%): 0.1502
　　Clear cell carcinoma 489 (85.8) 141 (82.5) 348 (87.2)
　　Non-clear cell carcinoma  81 (14.2)  30 (17.5)  51 (12.8)
CV-related diseases (%):
　　Diabetes  82 (14.4)  25 (14.6)  57 (14.3) 0.8972
　　Hypertension 187 (32.8)  63 (36.8) 124 (31.1) 0.2057
　　Cardiovascular disease  45 (7.9)  13 (7.6)  32 (8.0) 1.0000
　　Cerebrovascular disease  29 (5.1) 　8 (4.7)  21 (5.3) 0.8385
Median follow-up duration (months) (IQR)  57 (37-84)  54 (35-80)  58 (38-86) 0.1729























Months 0 12 24 36 48 60 72 84 96 108 120 132 144
RN 399 393 386 370 311 254 210 165 123 98 73 45 23























Months 0 12 24 36 48 60 72 84 96 108 120 132 144
eGFR<45 160 155 151 144 106 83 67 51 44 36 24 14 8
eGRF≥45 410 408 404 386 326 274 225 173 128 93 69 41 20
Fig. 1　 A,  Cumulative incidence of cardiovascular events stratiﬁed according to type of surgery (p＝0.1806).  Blue: partial nephrec-
tomy,  red: radical nephrectomy; B,  postoperative eGFR ≥45 vs. eGFR ＜45 (p＝0.0030).  Solid line: ＜45,  Dashed line: ≥45.
erative eGFR < 45 or ≥ 45 ml/min/1.73 m2,  the cumula-
tive CV event incidence differed significantly 
(p = 0.0030) (Fig. 1B).  The multivariate analysis showed 
that postoperative eGFR was the only factor that signifi-
cantly increased the risk of CV events (p = 0.0444) 
(Table 2).
In the patients with a preoperative eGFR ≥ 60,  the 
cumulative incidence rate of CV events showed a signif-
icant inverse correlation with postoperative eGFR 
(p < 0.0001) (Fig. 2).
Overall survival. Thirty-seven patients died 
during the study period,  including 5 (2.9%) in the PN 
group and 32 (8.0%) in the RN group.  Only three 
(0.5%) patients died of cardiovascular disease,  whereas 
11 (1.9%) patients died of RCC and 23 (4.0%) patients 
died of causes other than RCC or CV-related disease.  
The univariate analysis showed higher age,  lower 
(45 > ml/min/1.73 m2) preoperative and postoperative 
eGFR,  type of surgery (RN),  and T stage were factors 
that significantly increased the risk of death.  The multi-
variate analysis showed age,  preoperative eGFR,  and 
higher T stage (T1b) were significant determinants of 
OS but not postoperative eGFR (Table 3).
Discussion
Our study demonstrated that the type of surgery was 
not a significant risk factor for postoperative CV events,  
in contrast to 2 recent large retrospective studies that 
























Months 0 12 24 36 48 60 72 84 96 108 120 132 144
<45 102 102 100 91 67 50 42 31 26 21 15 10 5
45-60 175 175 172 168 141 120 99 75 53 42 34 21 15
≥60 246 245 239 227 193 164 139 108 83 57 42 27 10
Fig. 2　 Cumulative incidence of cardiovascular events stratiﬁed 
according to postoperative eGFR ≥60,  45-60,  and ＜45 in 
patients with a preoperative eGFR ≥60 (p＜0.0001).
Table 2　 Risk factors predicting cardiovascular events
Univariate Multivariate
Parameters HR (95% CI) p HR (95% CI) p
Male vs. Female 1.82 (0.83-4.54) 0.1363
Age　Unit risk 1.03 (0.99-1.06) 0.0505 1.01 (0.98-1.04) 0.4500
CV-related diseases:
　Preoperative diabetes
　　Yes vs. No 0.62 (0.15-1.74) 0.4015
　Preoperative hypertension
　　Yes vs. No 1.70 (0.85-3.34) 0.1315
　Preoperative cardiovascular disease
　　Yes vs. No 2.71 (1.08-5.90) 0.0346 2.20 (0.60-3.84) 0.4486
　Preoperative cerebrovascular disease
　　Yes vs. No 0.69 (0.04-3.22) 0.7030
Preoperative eGFR
　　＜45 vs.≧45 1.71 (0.41-4.80) 0.4100
Postoperative eGFR
　　＜45 vs.≧45 2.67 (1.34-5.24) 0.006 2.14 (1.02-4.47) 0.0444
Operation type:
　　PN vs. RN 0.55 (0.21-1.25) 0.1611 0.71 (0.26-1.66) 0.4486
pT stage:
　　pT1b vs. pT1a 1.46 (0.73-2.87) 0.2762
preop,  preoperative; postop,  postoperative; PN,  partial nephrectomy; RN,  radical nephrectomy.
showed that PN decreased the risk of postoperative CV 
events compared to RN [15].  Those 2 earlier studies 
analyzed patients who underwent RN and PN for clini-
cal T1 RCC,  with 3,103 patients in the SEER-Medicare 
database and 1,331 patients in a multi-institutional col-
laboration study.  The proportions of patients (PN vs. 
RN) who had experienced a CV event at 5 years were 
9.9% vs. 15.6% and 18% vs. 25% in the 2 studies,  
respectively.  On the other hand,  a meta-analysis 
including these 2 studies showed no significant differ-
ences in the pooled hazard ratio between PN and RN for 
CV events (HR = 0.86,  p = 0.238) [17].
An analysis of data from a large,  integrated system 
of healthcare delivery reported a nonlinear relationship 
between CV events and eGFR,  which rose sharply with 
an eGFR < 45 [1].  Takeshita et al.,  who demonstrated 
that postoperative renal function after an RN influenced 
CV events,  also showed that CV event-free survival 
differed significantly when the patients were stratified 
into 3 groups (eGFR ≥ 60,  45-60,  and < 45 (p < 0.001) 
[13].  Nakagawa et al.  analyzed the relationship between 
eGFR estimated using the MDRD equation and the 
severity of arterial stiffness using brachial-ankle pulse 
wave velocity in 647 adult Japanese patients,  and they 
suggested that eGFR < 45 might be a crucial cut-off 
value for predicting arterial stiffness in CKD.  [18] We 
therefore set eGFR < 45 as a cut-off in the present study,  
and our analyses revealed that the incidence of CV 
events became significantly different when the cohort 
was stratified into postoperative eGFR < 45 and ≥ 45 
(p = 0.003).  In addition,  when the cohort was limited to 
those who had normal renal function (eGFR ≥ 60),  the 
incidence of CV events increased as postoperative eGFR 
decreased.  Our findings confirmed that postoperative 
renal function was significantly better with a PN than 
with a RN and that postoperative renal function cor-
related significantly with the incidence of CV events.
These findings raise the question as to why PN did 
not significantly reduce the incidence of CV events in 
our study cohort.  The meta-analysis of CV events com-
paring PN and RN grouped according to publication 
year showed significant differences between the years 
2008-2010 versus 2011-2015.  The pooled hazard ratio 
(HR) published after 2011 indicated that PN signifi-
cantly reduced the risk of CV events (HR = 0.76,  
p = 0.035) [17].  This finding may reflect the develop-
ment of surgery using robotic systems.  In our PN 
cohort,  22% of the patients had undergone a laparo-
scopic PN,  and the remainder had an open PN.  Shiroki 
et al.  compared robotic-assisted partial nephrectomy 
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Table 3　 Risk factors predicting overall survival (OS)
Univariate Multivariate
Parameters HR (95% CI) p HR (95% CI) p
Sex　Male vs. female 0.69 (0.36-1.35) 0.2699
Age　Unit risk 1.06 (1.03-1.10) 0.0001 1.05 (1.01-1.09) 0.0100
CV-related diseases
　Preoperative diabetes
　　Yes vs. No 0.86 (0.26-2.17) 0.7723
　Preoperative hypertension
　　Yes vs. No 1.29 (0.65-2.49) 0.4552
　Preoperative cardiovascular disease
　　Yes vs. No 0.63 (0.10-2.05) 0.4882
　Preoperative cerebrovascular disease
　　Yes vs. No 2.79 (0.83-7.06) 0.0849 1.76 (0.50-4.81) 0.3433
Preoperative eGFR
　　＜45 vs.≧45 4.88 (2.08-10.18) 0.0007 3.45 (1.33-8.34) 0.0120
Postoperative eGFR
　　＜45 vs.≧45 2.38 (1.23-4.55) 0.0104 1.00 (0.45-2.14) 0.9981
Operation type
　　PN vs. RN 0.40 (0.04-0.14) 0.0350 0.78 (0.25-2.00) 0.6245
pT stage
　　pT1b vs. pT1a 2.94 (1.52-5.94) 0.0013 2.89 (1.41-6.23) 0.0033
preop,  preoperative; postop,  postoperative; PN,  partial nephrectomy; RN,  radical nephrectomy.
with other approaches and concluded that ischemia 
time appeared to be shorter in robotic-assisted PN than 
in laparoscopic PN,  in which postoperative renal func-
tion may vary [3].
We did not observe a relationship between OS and 
postoperative eGFR or demonstrate CV-related survival 
in the present study,  because only 3 patients in the 
study cohort died from cardiovascular disease.
Because CV events are critical,  preventing postop-
erative renal insufficiency and maintaining cancer con-
trol should be considered in all patients presenting with 
clinical T1 RCC.  Since 2016,  robot-associated PN has 
been covered by public healthcare insurance in Japan,  
and its use is increasing rapidly.  This technology may 
enable safe and effective operations and lead to more 
stable postoperative renal function [3].  It is important 
that efforts be made to minimize the iatrogenic renal 
insufficiency associated with renal surgery by minimiz-
ing ischemia time and by implementing surgical tech-
niques such as early declamping and superselective 
artery clamping to maintain postoperative eGFR as 
much as possible.
Our study has several limitations.  First,  it was a 
nonrandomized,  retrospective design.  Second,  inher-
ent selection bias may exist when comparing patients 
with small renal tumors who underwent different surgi-
cal procedures.  Third,  we did not evaluate the widely 
used indices such as the Karnofsky Performance Status 
Index or Charlson Comorbidity Index.  Fourth,  we 
defined the presence of underlying CV-related diseases 
according to medical records,  and did not evaluate the 
disease factors such as duration of suffering and medi-
cation in detail.  Lastly,  renal mass complexity includ-
ing the RENAL nephrometry score must be evaluated in 
future studies because of the wider range of eGFR 
changes,  especially in the PN group.  The only way to 
overcome this latter limitation would be to prospec-
tively randomize patients to either RN or PN; however,  
such a design would be considered unethical.
To date,  PN appears to be technically feasible in 
many patients with clinical T1 RCC.  Our study sug-
gests that renal dysfunction after surgery may present an 
independent risk of CV events.  It is therefore import-
ant to preserve renal function in patients with clinical 
T1 RCC under cancer control.
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